Willis Towers Watson 8.3
Source: RNSAp19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) |
J.P. Morgan Securities LLC |
Company dealt in |
Willis Towers Watson plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) |
US$0.000304635 ordinary shares |
Date of dealing |
23 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
|
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
1,796,374 1.39 |
1,760,114 1.36 |
||||
(2) Derivatives (other than options) |
1,584,055 1.23 |
1,616,265 1.25 |
||||
(3) Options and agreements to purchase/sell
|
2,000 0.00 |
26,000 0.02 |
||||
Total |
3,382,429 2.62 |
3,402,379 2.63 |
||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
Sale(Borrow Return)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales |
100
8 928 1 2 1 5 5 11
8 822 1 1 1 1 6 5 |
N/A
226.3400 USD 226.4100 USD 226.4300 USD 226.6250 USD 227.0700 USD 227.4900 USD 227.5000 USD 227.6264 USD
226.3400 USD 226.4100 USD 226.4300 USD 227.0700 USD 227.0800 USD 227.3200 USD 227.3750 USD 227.5000 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (USD) (Note 5) |
Equity Swap |
Decrease Long |
1 |
226.4300 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price (USD) |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) (USD) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
Date of disclosure |
26 July 2021 |
Contact name |
Alwyn Basch |
Telephone number |
0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected |
N/A |
If a connected EFM, state nature of connection (Note 10) |
N/A |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, e.g. call option |
Written, or purchased |
Number of relevant securities to which the option or derivative relates |
Exercise price (Note 2) (USD) |
Type, e.g. American, European etc. |
Expiry date |
Call Option Call Option Put Option
|
Purchased Written Written
|
2,000 2,000 24,000
|
230.00 230.00 220.00
|
American American American
|
17/09/2021 20/08/2021 20/08/2021
|
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.